Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder

Name: Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder
SKU: 3230
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 2 Articles Tags: antidepressant, anxiolytic, generalized-anxiety-disorder, medworks-media, pharmacotherapy, philip-t-ninan, psychopharmacology-bulletin

Description

Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder

Description

Philip T. Ninan, MD

GENERAL PSYCHOPHARMACOLOGY

New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder

Philip T. Ninan, MD

What Mood Symptoms may be most Difficult to Rate?

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder

Description

Philip T. Ninan, MD

GENERAL PSYCHOPHARMACOLOGY

New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder

Philip T. Ninan, MD

Related products

What Mood Symptoms may be most Difficult to Rate?

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan